Global Biophotonics Industry
by PR Newswire
NEW YORK, Sept. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0960416/Global-Biophotonics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics
This report analyzes the worldwide markets for Biophotonics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 90 companies including many key and niche players such as AdvanDx, Inc., Affymetrix, Inc., Andor Technology plc, Becton, Dickinson and Company, BioTek Instruments, Inc., BIOLASE Technology, Inc., Caliper Life Sciences, Inc., Cambridge Research & Instrumentation, Inc., Carl Zeiss MicroImaging GmbH, CEA-Leti, Endra, Inc., Epi-Light Limited, Glenbrook Technologies, Hamamatsu Photonics K.K., HORIBA, Ltd., Lumenis Ltd., Newport Corporation, Ocean Optics, Inc., Olympus America, Inc., PerkinElmer, Inc., Photocure ASA, PicoQuant GmbH, Solta Medical, Inc., Technolas Perfect Vision GmbH, TILL Photonics GmbH, Zecotek Photonics, Inc., and Zenalux Biomedical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
A Prelude II-1
Current and Future Analysis II-1
Analysis by Region II-1
Analysis by Application II-2
Multi-Modal Biophotonics to Enable Accurate and Early Disease
Diagnosis II-2
Cancer II-2
Ovarian Cancer II-2
Coronary Artery Diseases II-3
Biophotonics-Based Diagnostics - A Tool for Curbing Influenza
Outbreaks II-3
Biophotonics Used for Enhancing Fish Supply Globally II-3
Biophotonics Finds Applicability in Ensuring Food Safety II-4
OMI Expected to Revolutionize Methodologies for Diagnosing and
Treating Diseases II-4
Global Biophotonics Market - Wider Applications Purview II-4
Medical Biophotonics II-5
Cellular and Molecular Biophotonics II-5
2. PRODUCT OVERVIEW II-6
An Introduction II-6
Definition II-6
Select Light Sources for Biophotonics II-6
Gas Lasers II-6
Diode Lasers II-7
Applications II-7
Use of Biophotonics in Diagnostics II-7
Role of Biophotonics in Therapeutics II-7
Application of Biophotonics in Biotechnology II-8
Other Emerging Applications of Biophotonics II-8
Optical Sectional Microscopy II-8
Photon Limited Microscopy II-8
Fluorescence Microscopy II-8
Time-Resolved Fluorescence Spectroscopy II-8
Fluorescence Lifetime Imaging Microscopy II-9
Caged Bioactive Probes II-9
3. PRODUCT INTRODUCTIONS/LAUNCHES II-10
Thorlabs Introduces B-Scope Multiphoton Imaging System II-10
Life Technologies Launches FLoid Cell Imaging Platform II-10
Photonis Unveils xSCELL Digital Scientific Camera II-10
Hamamatsu Photonics to Unveil New ORCA-Flash4.0 Scientific Camera II-11
Applied Scientific Instrumentation Introduces CRISP Autofocus
System II-11
PEQLAB Launches EVOS xl Core Brightfield Microscope II-11
Ocean Optics Unveils Novel Fiber-Optic Sensors II-12
Olympus Unveils New DP73WDR and DP73 Digital Cameras II-12
TILL Photonics Launches Intravital2P II-13
Epi-Light Introduces New Range of UV LED Emitters II-13
Zenalux Biomedical to Introduce Zenascope PC1 II-13
BIOLASE Introduces Waterlase® iPlusTM All-Tissue Dual-
Wavelength Laser II-14
Spectra-Physics® Launches Mosaic 532-11 Industrial Laser II-14
Andor Technology Introduces iStar Series of ICCDs II-14
Olympus America Introduces New BX3® Microscope Series II-15
Endra Life Sciences Introduces Nexus 128 Photoacoustic
Computed Tomography Scanner II-16
Cambridge Research & Instrumentation Introduces TRIOTM Imaging
Technology II-16
Bionic Vision Australia to Introduce Bionic Eye II-17
Carestream Health Launches Kodak In-Vivo Multispectral Imaging
System FX II-17
TILL Photonics Launches iMIC-Andromeda II-17
AdvanDX Unveils GNR Traffic LightTM PNA FISH® II-17
Andor Technology Rolls Out iXonEM Blue EMCCD II-18
BD Biosciences Introduces BD InfluxTM Cell Sorting System II-18
BioTek Instruments Launches Synergy H1 Hybrid Multi-Mode
Microplate Reader II-18
Spectra-Physics® Unveils The Explorer® XP 532-5 Laser II-19
Newport Launches Laser Diode Control Kits II-19
Lumenis Unveils FiberLaseTM CO2 Fiber and AcuPulseTM 40WG CO2
Laser System II-19
Endra Life Sciences Introduces Nexus 128 System II-20
BioTek Instruments Introduces Epoch Multi-Volume
Spectrophotometer System II-20
BIOLASE Technology Unveils New Waterlase® MD TurboTM Dental
Laser System II-21
Caliper Life Sciences Unveils IVIS Lumina XR Imaging System II-21
Lumenis Unveils AcuPulseTM Fractional CO2 Laser System II-21
Olympus Launches UIS2 Version of SUPER 20x Microscope Objective II-21
Solta Medical Introduces New Fraxel re:store® DUAL System II-22
Newport Introduces Excelsior® and Cyan™ Lasers II-22
4. RECENT INDUSTRY ACTIVITY II-23
NinePoint Medical Obtains FDA Approval for Nvision VLE
Volumetric OCT Device II-23
Nikon Instruments Inks Agreement with Agilent Technologies II-23
Zenalux Biomedical Licenses Spectral Analysis Algorithm from WARF II-23
AdvanDx Obtains US FDA 510(k) Clearance for GNR Traffic Light™
PNA FISH® Test II-24
Technolas Perfect Vision Obtains US FDA Approval for ZYOPTIX®
Advanced Nomogram II-24
TrueVision Systems Obtains US FDA 510(k) Clearance for
TrueVision 3D Visualization and Guidance System II-24
Cynosure Receives International Regulatory Approvals for
SmoothShapes XV and Smartlipo Triplex II-25
BIOLASE Technology Establishes Biolase Imaging Division II-25
University of California, Davis and Boston University to Co-
Establish New Research Center II-25
St Jude Medical Obtains FDA Clearance for ILUMIEN System II-25
PEQLAB Becomes Sole Exclusive Distributor of AMG EVOS Digital
Microscopes in Ireland and UK II-26
Caliper Life Sciences Purchases Cambridge Research &
Instrumentation II-26
PerkinElmer Takes Over VisEn Medical II-27
Ocean Optics Buys Sandhouse Design II-27
MedX Health Takes Over Canadian Operations of Reimers & Janssen II-27
St. Jude Medical Takes Over LightLab Imaging II-28
Danaher Purchases Analytical Technologies Division of MDS II-28
LenSx Lasers Receives US FDA Approval for LenSx Femtosecond Laser II-28
Solta Medical Obtains US FDA 510(k) Clearance for Fraxel re:
store Dual Laser System II-29
GE Healthcare Obtains US FDA Approval for Cysview Optical
Imaging Agent II-29
LightLab Imaging Receives US FDA Approval for C7-XR Imaging
System and C7 Dragonfly Imaging Catheter II-29
Candela Receives SFDA Approval for GentleMax Laser System and
Alex TriVantage Q-Switched Laser System II-30
Palomar Medical Technologies Receives US FDA Approval for
Lux1540 Fractional Non-Ablative Laser Handpiece II-30
BIOLASE Technology Inks Agreement with P&G II-30
Ocean Optics Asia Obtains ISO 9001:2008 Certification II-30
Bayer Schering Pharma and Hamamatsu Photonics Sign Licensing
Agreement II-31
5. FOCUS ON SELECT GLOBAL PLAYERS II-32
AdvanDx, Inc. (US) II-32
Affymetrix, Inc. (US) II-32
Andor Technology plc (Ireland) II-32
Becton, Dickinson and Company (US) II-32
BioTek Instruments, Inc. (US) II-33
BIOLASE Technology, Inc. (US) II-33
Caliper Life Sciences, Inc. (US) II-34
Cambridge Research & Instrumentation, Inc. (US) II-34
Carl Zeiss MicroImaging GmbH (Germany) II-34
CEA-Leti (France) II-35
Endra, Inc. (US) II-35
Epi-Light Limited (Ireland) II-35
Glenbrook Technologies (US) II-35
Hamamatsu Photonics K.K. (Japan) II-36
HORIBA, Ltd. (Japan) II-36
Lumenis Ltd. (Israel) II-36
Newport Corporation (US) II-36
Ocean Optics, Inc. (US) II-37
Olympus America, Inc. (US) II-37
PerkinElmer, Inc. (US) II-37
Photocure ASA (Norway) II-38
PicoQuant GmbH (Germany) II-38
Solta Medical, Inc. (US) II-38
Technolas Perfect Vision GmbH (Germany) II-38
TILL Photonics GmbH (Germany) II-39
Zecotek Photonics, Inc. (Singapore) II-39
Zenalux Biomedical, Inc. (US) II-39
6. GLOBAL MARKET PERSPECTIVE II-40
Table 1: World Recent Past, Current and Future Analysis for
Biophotonics by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Revenues in US$ Million for
Years 2010 through 2018 (includes corresponding Graph/Chart) II-40
Table 2: World Historic Review for Biophotonics by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) II-41
Table 3: World 15-Year Perspective for Biophotonics by
Geographic Region - Percentage Breakdown of Dollar Sales for
Markets for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World for Years 2004, 2011 & 2018
(includes corresponding Graph/Chart) II-42
Table 4: World Recent Past, Current and Future Analysis for
Medical Applications of Biophotonics by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-43
Table 5: World Historic Review for Medical Applications of
Biophotonics by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Revenues in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) II-44
Table 6: World 15-Year Perspective for Medical Applications of
Biophotonics by Geographic Region - Percentage Breakdown of
Dollar Sales for Markets for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World for Years
2004, 2011 & 2018 (includes corresponding Graph/Chart) II-45
Table 7: World Recent Past, Current and Future Analysis for
Application of Medical Biophotonics in Therapeutics by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Revenues in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) II-46
Table 8: World Historic Review for Application of Medical
Biophotonics in Therapeutics by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-47
Table 9: World 15-Year Perspective for Application of Medical
Biophotonics in Therapeutics by Geographic Region - Percentage
Breakdown of Dollar Sales for Markets for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-48
Table 10: World Recent Past, Current and Future Analysis for
Application of Medical Biophotonics in Diagnostics by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Revenues in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) II-49
Table 11: World Historic Review for Application of Medical
Biophotonics in Diagnostics by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Revenues in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-50
Table 12: World 15-Year Perspective for Application of Medical
Biophotonics in Diagnostics by Geographic Region - Percentage
Breakdown of Dollar Sales for Markets for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-51
Table 13: World Recent Past, Current and Future Analysis for
Application of Medical Biophotonics in Others by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-52
Table 14: World Historic Review for Application of Medical
Biophotonics in Others by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Revenues in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-53
Table 15: World 15-Year Perspective for Application of Medical
Biophotonics in Others by Geographic Region - Percentage
Breakdown of Dollar Sales for Markets for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-54
Table 16: World Recent Past, Current and Future Analysis for
Non-Medical Applications of Biophotonics by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
and Rest of World Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-55
Table 17: World Historic Review for Non-Medical Applications
of Biophotonics by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Revenues in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-56
Table 18: World 15-Year Perspective for Non-Medical
Applications of Biophotonics by Geographic Region - Percentage
Breakdown of Dollar Sales for Markets for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-57
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Outlook III-1
Product Launches III-1
Strategic Corporate Developments III-10
Focus on Select Players III-16
B.Market Analytics III-22
Table 19: US Recent Past, Current and Future Analysis for
Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non-Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-22
Table 20: US Historic Review for Biophotonics by Application -
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-23
Table 21: US 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-24
2. CANADA III-25
A.Market Analysis III-25
Outlook III-25
Strategic Corporate Developments III-25
B.Market Analytics III-27
Table 22: Canadian Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non-Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-27
Table 23: Canadian Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-28
Table 24: Canadian 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-29
3. JAPAN III-30
A.Market Analysis III-30
Outlook III-30
Product Launch III-30
Strategic Corporate Development III-30
Focus on Select Regional Players III-31
B.Market Analytics III-32
Table 25: Japanese Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non-Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-32
Table 26: Japanese Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-33
Table 27: Japanese 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-34
4. EUROPE III-35
A.Market Analysis III-35
Outlook III-35
B.Market Analytics III-36
Table 28: European Recent Past, Current and Future Analysis
for Biophotonics by Country/Region - France, Germany, Italy,
UK, Spain, Russia, and Rest of Europe Markets Independently
Analyzed with Annual Revenues in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-36
Table 29: European Historic Review for Biophotonics by
Country/Region - France, Germany, Italy, UK, Spain, Russia,
and Rest of Europe Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-37
Table 30: European 15-Year Perspective for Biophotonics by
Country/Region - Percentage Breakdown of Dollar Sales for
France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-38
Table 31: European Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non- Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-39
Table 32: European Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-40
Table 33: European 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-41
4a. FRANCE III-42
A.Market Analysis III-42
Outlook III-42
B.Market Analytics III-43
Table 34: French Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non- Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-43
Table 35: French Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-44
Table 36: French 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-45
4b. GERMANY III-46
A.Market Analysis III-46
Outlook III-46
Product Launches III-46
Focus on Select Regional Player III-48
B.Market Analytics III-50
Table 37: German Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non- Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-50
Table 38: German Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-51
Table 39: German 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-52
4c. ITALY III-53
A.Market Analysis III-53
Outlook III-53
B.Market Analytics III-54
Table 40: Italian Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non- Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-54
Table 41: Italian Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-55
Table 42: Italian 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-56
4d. THE UNITED KINGDOM III-57
A.Market Analysis III-57
Outlook III-57
Product Launch III-57
Strategic Corporate Development III-57
B.Market Analytics III-58
Table 43: UK Recent Past, Current and Future Analysis for
Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non-Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-58
Table 44: UK Historic Review for Biophotonics by Application
- Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-59
Table 45: UK 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-60
4e. SPAIN III-61
A.Market Analysis III-61
Outlook III-61
Focus on Select Regional Player III-61
B.Market Analytics III-62
Table 46: Spanish Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non- Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-62
Table 47: Spanish Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-63
Table 48: Spanish 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-64
4f. RUSSIA III-65
A.Market Analysis III-65
Outlook III-65
INJECT Enterprise - A Major Player III-65
B.Market Analytics III-66
Table 49: Russian Recent Past, Current and Future Analysis
for Biophotonics by Application - Medical (Therapeutics,
Diagnostics, and Others) and Non- Medical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-66
Table 50: Russian Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-67
Table 51: Russian 15-Year Perspective for Biophotonics by
Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-68
4g. REST OF EUROPE III-69
A.Market Analysis III-69
Outlook III-69
Product Launches III-69
Focus on Select Regional Players III-70
B.Market Analytics III-72
Table 52: Rest of Europe Recent Past, Current and Future
Analysis for Biophotonics by Application - Medical
(Therapeutics, Diagnostics, and Others) and Non-Medical
Markets Independently Analyzed with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-72
Table 53: Rest of Europe Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-73
Table 54: Rest of Europe 15-Year Perspective for
Biophotonics by Application - Percentage Breakdown of Dollar
Sales for Medical (Therapeutics, Diagnostics, and Others)
and Non-Medical Markets for Years 2004, 2011 & 2018
(includes corresponding Graph/Chart) III-74
5. ASIA-PACIFIC III-75
A.Market Analysis III-75
Outlook III-75
Product Launch III-75
Strategic Corporate Developments III-76
Zecotek Photonics, Inc. - A Major Biophotonics Company in
Asia-Pacific Region III-76
B.Market Analytics III-77
Table 55: Asia-Pacific Recent Past, Current and Future
Analysis for Biophotonics by Application - Medical
(Therapeutics, Diagnostics, and Others) and Non- Medical
Markets Independently Analyzed with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-77
Table 56: Asia-Pacific Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-78
Table 57: Asia-Pacific 15-Year Perspective for Biophotonics
by Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-79
6. REST OF WORLD III-80
A.Market Analysis III-80
Outlook III-80
Product Launches III-80
B.Market Analytics III-82
Table 58: Rest of World Recent Past, Current and Future
Analysis for Biophotonics by Application - Medical
(Therapeutics, Diagnostics, and Others) and Non-Medical
Markets Independently Analyzed with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-82
Table 59: Rest of World Historic Review for Biophotonics by
Application - Medical (Therapeutics, Diagnostics, and
Others) and Non-Medical Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-83
Table 60: Rest of World 15-Year Perspective for Biophotonics
by Application - Percentage Breakdown of Dollar Sales for
Medical (Therapeutics, Diagnostics, and Others) and
Non-Medical Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-84
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 90 (including Divisions/Subsidiaries - 94)
The United States (51)
Canada (2)
Japan (4)
Europe (33)
- France (2)
- Germany (10)
- The United Kingdom (3)
- Spain (2)
- Rest of Europe (16)
Asia-Pacific (Excluding Japan) (3)
Middle East (1)
To order this report:
Diagnostics Industry: Global Biophotonics Industry
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
